One-time gene therapy reverses liver disease MASH in mouse models
FGF21 is a key metabolic regulator that ... This treatment mediates long-term reversal of liver fibrosis and MASH, ...
News Medical1 个月
UAB researchers reverse liver disease in mice with gene therapy
FGF21 is a key metabolic regulator that ... This treatment mediates long-term reversal of liver fibrosis and MASH, counteracts obesity, excessive fat accumulation, insulin resistance ...